Course introduction: The UK NHS Newborn Hearing Screening Program (NHSP) has been a huge success, but every now and then parents and clinicians question whether the NHSP protocol is optimal
The UK NHS Newborn Hearing Screening Program (NHSP) has been a huge success, but every now and then parents and clinicians question whether the NHSP protocol is optimal in identifying all children with hearing loss. This talk will focus on challenges and opportunities around the identification of Auditory Neuropathy Spectrum Disorder.
At the conclusion of this seminar the participants will be able to:
• Discuss epidemiology, etiopathogenesis, clinical presentation and prognosis of ANSD in paediatric population
• Critically evaluate the evidence for and against reviewing the current NHSP protocol
• Consider possibilities of better identifying and diagnosing ANSD in young infants
CE Credits: This course is valid for 1.0 CE Contact hours.
Required provider statement – mark the correct one or add the one to be used
Natus Medical Incorporated is a Provider approved by the California Board of Registered Nursing, Provider Number 16614, for 1.0 contact hours
Speakers for this event
Dr Kai Uss
Dr Kai Uss
Dr Kai Uss is a paediatrician by background, but quite early on in her career developed an interest in paediatric audiology. She came to the UK in 1998 as a Wellcome Trust Research Fellow to do her PhD in Audiological Medicine. After completing her thesis, Prof John Bamford invited her to work with him on the evaluation of the NHS Newborn Hearing Screening Programme (NHSP) in England. Her research interest is primarily in Auditory Neuropathy Spectrum Disorder primarily in infants, but also in adult patient populations. Dr Uss is the ManCAD Teaching Lead as well as the programme director for the Scientist Training Programme in Neurosensory Science and an academic lead for Higher Specialist Scientific Training in Audiological Science at the University of Manchester.
(Thursday) 11:00 am - 12:00 pm EST